Dr. Tjark C. Schliep, MD

Dr. Schliep practices at NYC Health and Hospitals/Harlem in New York, New York.

Dr. Schliep's NPI, 1649291808, was assigned on July 22, 2006. Dr. Schliep holds New York license 000887.

Dr. Schliep's primary practice is NYC Health and Hospitals/Harlem, at 506 Malcolm X Blvd, New York, NY 10037 in New York County. The practice phone is (212) 939-2027.

Dr. Schliep's primary practice is NYC Health and Hospitals/Harlem in New York, New York. Dr. Schliep is also affiliated with NYC Health + Hospitals/Harlem. The medical group on file is Physician Affiliate Group of New York (PAGNY). Dmand AI also links Dr. Schliep to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schliep practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Schliep's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Schliep is licensed in New York.

CMS data shows 39 Medicare services from Dr. Schliep across 1 procedure code in 2024, for 53 Medicare patients. Medicare paid $4,435 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Schliep in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schliep's median patient age at 64, with 46% women.

In 2024, Dr. Schliep wrote 1,239 Medicare Part D claims for 53 patients. 61% of them were for generic drugs. CMS names the drug for 1,053 of them, across 41 drugs with 11 or more claims each, at $1,182,615 in total drug cost. In 2023, CMS named 880 claims across 34 drugs.

Dr. Schliep accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Schliep from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $96.